CII
STJ

CR Intrinsic Investors’s St Jude Medical STJ Stock Holding History

CR Intrinsic Investors’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-110,000
Closed -$7.19M – 223
2014
Q1 		$7.19M Buy
+110,000
New +$7.16M 0.27% 132

Other funds holding STJ

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IIS
Ignis Investment Services Edinburgh, United Kingdom $29.9B AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

CR Intrinsic Investors's STJ Position: Q2 2014 in Review

CR Intrinsic Investors sold out of St Jude Medical (STJ) in Q2 2014, closing a stake of 110,000 shares — an estimated $7.19M sold.

CR Intrinsic Investors first reported a position in STJ in Q1 2014 and held it in 1 quarter. The position peaked at $7.19M in Q1 2014. 555 funds tracked by Wall St. Rank hold STJ as of Q2 2014.

  • CR Intrinsic Investors reported no remaining St Jude Medical position as of Q2 2014 after selling out during the quarter.
  • CR Intrinsic Investors sold 110,000 St Jude Medical shares in Q2 2014, an estimated $7.19M.
  • CR Intrinsic Investors first reported a position in St Jude Medical in Q1 2014 and held it in 1 quarter.
  • CR Intrinsic Investors's St Jude Medical position peaked at $7.19M in Q1 2014.
  • 555 funds tracked by Wall St. Rank held St Jude Medical as of Q2 2014.

Based on CR Intrinsic Investors's 13F filing for Q2 2014.